Universe Pharmaceuticals (UPC) Short term Debt: 2020-2024
Historic Short term Debt for Universe Pharmaceuticals (UPC) over the last 5 years, with Sep 2024 value amounting to $5.9 million.
- Universe Pharmaceuticals' Short term Debt rose 6.83% to $5.9 million in Q3 2024 from the same period last year, while for Sep 2024 it was $5.9 million, marking a year-over-year increase of 6.83%. This contributed to the annual value of $5.9 million for FY2024, which is 6.83% up from last year.
- According to the latest figures from FY2024, Universe Pharmaceuticals' Short term Debt is $5.9 million, which was up 6.83% from $5.5 million recorded in FY2023.
- Over the past 5 years, Universe Pharmaceuticals' Short term Debt peaked at $956.5 billion during FY2020, and registered a low of $19,723 during FY2021.
- Over the past 3 years, Universe Pharmaceuticals' median Short term Debt value was $5.5 million (recorded in 2023), while the average stood at $4.9 million.
- Per our database at Business Quant, Universe Pharmaceuticals' Short term Debt plummeted by 100.00% in 2021 and then soared by 17,033.62% in 2022.
- Yearly analysis of 5 years shows Universe Pharmaceuticals' Short term Debt stood at $956.5 billion in 2020, then plummeted by 100.00% to $19,723 in 2021, then surged by 17,033.62% to $3.4 million in 2022, then spiked by 62.24% to $5.5 million in 2023, then rose by 6.83% to $5.9 million in 2024.